ITUS Corporation announced that its Board of Directors has appointed Dr. Amit Kumar as its new President and Chief Executive Officer. Dr. Kumar
replaces Mr. Robert Berman, who has resigned as President, CEO and as a Director. In addition, Mike Catelani, ITUS' CFO, has been promoted to Chief Operating Officer (COO). Dr. Kumar has served as the company's Executive Chairman for the past year, and has been a Director since joining the Company in 2012. He has served as CEO of public and private biotechnology companies, and currently serves on multiple corporate boards, as well as the Board of the American Cancer Society. Dr. Kumar has over 25 years of experience working in cancer research and the biotech industry as a scientist, entrepreneur, CEO, board member and investor. Previously, Dr. Kumar was CEO of CombiMatrix, he took public and ran from 2001 to 2010. Since 2010, Dr. Kumar has co-founded and guided a number of biotechnology enterprises, including ITUS as it transitioned into a biotechnology company. Mike Catelani joined ITUS in November 2016 as CFO of the company, and is now taking on the additional title and responsibility of COO. Mike's experience includes senior strategic, operations, and finance roles in a number of biotechnology companies. Mike has been instrumental in founding, running, and raising capital for his companies.